|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-10-31
|
|
pubmed:abstractText |
Transmyocardial revascularization reduces the symptoms and morbidity of patients with endstage ischemic heart disease. The mechanism is postulated to be the formation of transmural left ventricular channels through which oxygenated blood directly perfuses the myocardium. New techniques for molecular enhancement of angiogenesis and endothelial cell motility may represent strategies to augment this clinical benefit.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1051-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8823089-Adenoviridae,
pubmed-meshheading:8823089-Animals,
pubmed-meshheading:8823089-Cardiac Surgical Procedures,
pubmed-meshheading:8823089-Contractile Proteins,
pubmed-meshheading:8823089-Coronary Circulation,
pubmed-meshheading:8823089-Endothelial Growth Factors,
pubmed-meshheading:8823089-Genetic Vectors,
pubmed-meshheading:8823089-Laser Therapy,
pubmed-meshheading:8823089-Microfilament Proteins,
pubmed-meshheading:8823089-Myocardial Revascularization,
pubmed-meshheading:8823089-Myocardium,
pubmed-meshheading:8823089-Neovascularization, Physiologic,
pubmed-meshheading:8823089-Profilins,
pubmed-meshheading:8823089-Swine
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
One-month histologic response of transmyocardial laser channels with molecular intervention.
|
|
pubmed:affiliation |
Division of Cardiac Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
|
|
pubmed:publicationType |
Journal Article
|
